{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T05:14:25Z","timestamp":1740114865671,"version":"3.37.3"},"reference-count":87,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,30]],"date-time":"2024-12-30T00:00:00Z","timestamp":1735516800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.intimp.2024.113998","type":"journal-article","created":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T13:44:15Z","timestamp":1736171055000},"page":"113998","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["3,6-Anhydro-L-galactose suppresses mouse lymphocyte proliferation by attenuating JAK-STAT growth factor signal transduction and G1-S cell cycle progression"],"prefix":"10.1016","volume":"147","author":[{"given":"Shin Young","family":"Park","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ki Yun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Won Young","family":"Jang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Young-Seuk","family":"Bae","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Do Youn","family":"Jun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Young Ho","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.intimp.2024.113998_b0005","doi-asserted-by":"crossref","first-page":"332","DOI":"10.2215\/CJN.08570814","article-title":"Immunosuppressive medications","volume":"11","author":"Wiseman","year":"2016","journal-title":"Clin. J. Am. Soc. Nephrol."},{"issue":"2\u20133","key":"10.1016\/j.intimp.2024.113998_b0010","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0162-3109(00)00186-7","article-title":"Immunosuppressive drugs: the first 50 years and a glance forward","volume":"47","author":"Allison","year":"2000","journal-title":"Immunopharmacology"},{"issue":"25","key":"10.1016\/j.intimp.2024.113998_b0015","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1056\/NEJMra064928","article-title":"Infection in solid-organ transplant recipients","volume":"357","author":"Fishman","year":"2007","journal-title":"N. Engl. J. Med."},{"issue":"1 Suppl","key":"10.1016\/j.intimp.2024.113998_b0020","first-page":"s12","article-title":"An overview of immunosuppression in solid organ transplantation","volume":"21","author":"Enderby","year":"2015","journal-title":"Am. J. Manag. Care"},{"key":"10.1016\/j.intimp.2024.113998_b0025","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1056\/NEJMoa1506027","article-title":"Belatacept and long-term outcomes in kidney transplantation","volume":"374","author":"Vincenti","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.intimp.2024.113998_b0030","article-title":"Immunosuppressive drugs modes of action","volume":"54\u201355","author":"Meneghini","year":"2021","journal-title":"Best Pract. Res. Clin. Gastroenterol."},{"key":"10.1016\/j.intimp.2024.113998_b0035","doi-asserted-by":"crossref","first-page":"14","DOI":"10.29245\/2578-3009\/2019\/4.1178","article-title":"Immunosuppressive drugs in organ transplantation to prevent allograft rejection: Mode of action and side effects","volume":"3","author":"Claeys","year":"2019","journal-title":"J. Immunol. Sci."},{"key":"10.1016\/j.intimp.2024.113998_b0040","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.critrevonc.2005.03.012","article-title":"Immunosuppressive agents in solid organ transplantation: Mechanisms of action and therapeutic efficacy","volume":"56","author":"Taylor","year":"2005","journal-title":"Crit. Rev.oncol. Hematol."},{"key":"10.1016\/j.intimp.2024.113998_b0045","first-page":"S12","article-title":"An overview of immunosuppression in solid organ transplantation","volume":"21","author":"Enderby","year":"2015","journal-title":"Am. J. Manag. Care"},{"issue":"Pt B","key":"10.1016\/j.intimp.2024.113998_b0050","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.ijsu.2015.06.066","article-title":"The need for xenotransplantation as a source of organs and cells for clinical transplantation","volume":"23","author":"Ekser","year":"2015","journal-title":"Int. J. Surg."},{"issue":"5","key":"10.1016\/j.intimp.2024.113998_b0055","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1111\/j.1399-3089.2009.00534.x","article-title":"Current status of xenotransplantation and prospects for clinical application","volume":"16","author":"Pierson","year":"2009","journal-title":"Xenotransplantation"},{"key":"10.1016\/j.intimp.2024.113998_b0060","article-title":"Current status of xenotransplanta tion research and the strategies for preventing xenograft rejection","volume":"13","author":"Zhou","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2024.113998_b0065","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.899657","article-title":"Progress in xenotransplantation: Immunologic barriers, advances in gene editing, and successful tolerance induction strategies in pig-to- primate transplantation","volume":"13","author":"Eisenson","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2024.113998_b0070","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1056\/NEJMoa021744","article-title":"Chronic renal failure after transplantation of a nonrenal organ","volume":"349","author":"Ojo","year":"2003","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.intimp.2024.113998_b0075","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1021\/acs.biomac.0c01406","article-title":"Hydrogel-forming algae polysaccharides: From seaweed to biomedical applications","volume":"22","author":"Beaumont","year":"2021","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.intimp.2024.113998_b0080","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0008-6215(00)86113-3","article-title":"The structure of agar: Part I. Fractionation of a complex mixture of polysaccharides","volume":"16","author":"Duckworth","year":"1971","journal-title":"Carbohydr. Res."},{"key":"10.1016\/j.intimp.2024.113998_b0085","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1007\/s00253-012-4023-2","article-title":"Agar degradation by microorganisms and agar-degrading enzymes","volume":"94","author":"Chi","year":"2012","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"10.1016\/j.intimp.2024.113998_b0090","doi-asserted-by":"crossref","first-page":"13985","DOI":"10.1074\/jbc.M112.345645","article-title":"Analysis of keystone enzyme in agar hydrolysis provides insight into the degradation (of a polysaccharide from) red seaweeds","volume":"287","author":"Hehemann","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.intimp.2024.113998_b0095","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.procbio.2011.12.015","article-title":"Successful preparation and characterization of biotechnological grade agarose from indigenous Gelidium amansii of Taiwan","volume":"47","author":"Wang","year":"2012","journal-title":"Process Biochem."},{"issue":"5","key":"10.1016\/j.intimp.2024.113998_b0100","doi-asserted-by":"crossref","first-page":"299","DOI":"10.3390\/md21050299","article-title":"Extraction, modification and biomedical application of agarose hydrogels: A review","volume":"21","author":"Jiang","year":"2023","journal-title":"Mar. Drugs"},{"key":"10.1016\/j.intimp.2024.113998_b0105","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/nature08937","article-title":"Transfer of carbohydrate-active enzymes from marine bacteria to Japanese gut microbiota","volume":"464","author":"Hehemann","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.intimp.2024.113998_b0110","doi-asserted-by":"crossref","first-page":"34103","DOI":"10.1038\/srep34103","article-title":"Horizontal transfer of a novel soil agarase gene from marine bacteria to soil bacteria via human microbiota","volume":"6","author":"Song","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.intimp.2024.113998_b0115","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1038\/s41467-018-03366-x","article-title":"Molecular basis of an agarose metabolic pathway acquired by a human intestinal symbiont","volume":"9","author":"Pluvinage","year":"2018","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.intimp.2024.113998_b0120","doi-asserted-by":"crossref","first-page":"13955","DOI":"10.1038\/s41598-021-92872-y","article-title":"Metabolic and enzymatic elucidation of cooperative degradation of red seaweed agarose by two human gut bacteria","volume":"11","author":"Yun","year":"2021","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.intimp.2024.113998_b0125","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.3390\/molecules23061354","article-title":"Quantification of neoagaro-oligosaccharide production through enzymatic hydrolysis and its anti-oxidant activities","volume":"23","author":"Xu","year":"2018","journal-title":"Molecules"},{"issue":"4","key":"10.1016\/j.intimp.2024.113998_b0130","doi-asserted-by":"crossref","first-page":"213","DOI":"10.3390\/md19040213","article-title":"In vitro prebiotic and anti-colon cancer activities of agar-derived sugars from red seaweeds","volume":"19","author":"Yun","year":"2021","journal-title":"Mar. Drugs"},{"key":"10.1016\/j.intimp.2024.113998_b0135","doi-asserted-by":"crossref","first-page":"44252","DOI":"10.1038\/srep44252","article-title":"Neoagaro-oligosaccharide monomers inhibit inflammation in LPS-stimulated macrophages through suppression of MAPK and NF-\u03baB pathways","volume":"7","author":"Wang","year":"2017","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.intimp.2024.113998_b0140","doi-asserted-by":"crossref","first-page":"90","DOI":"10.3390\/md15040090","article-title":"Anti-obesity and anti-diabetic effect of neoagarooligosaccharides on high-fat diet-induced obesity in mice","volume":"15","author":"Hong","year":"2017","journal-title":"Mar. Drugs"},{"issue":"5","key":"10.1016\/j.intimp.2024.113998_b0145","doi-asserted-by":"crossref","first-page":"263","DOI":"10.5483\/BMBRep.2017.50.5.014","article-title":"Neoagarohexaose-mediated activation of dendritic cells via toll-like receptor 4 leads to stimulation of natural killer cells and enhancement of antitumor immunity","volume":"50","author":"Lee","year":"2017","journal-title":"BMB Rep."},{"issue":"1","key":"10.1016\/j.intimp.2024.113998_b0150","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1271\/bbb.61.162","article-title":"Neoagarobiose as a novel moisturizer with whitening effect","volume":"61","author":"Kobayashi","year":"1997","journal-title":"Biosci. Biotech. Bioch."},{"key":"10.1016\/j.intimp.2024.113998_b0155","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1002\/mnfr.201600585","article-title":"Neoagarotetraose protects mice against intense exercise-induced fatigue damage by modulating gut microbial composition and function","volume":"61","author":"Zhang","year":"2017","journal-title":"Mol. Nutr. Food Res."},{"issue":"7","key":"10.1016\/j.intimp.2024.113998_b0160","doi-asserted-by":"crossref","first-page":"2961","DOI":"10.1007\/s00253-012-4184-z","article-title":"Enzymatic production of 3,6-anhydro-L-galactose from agarose and its purification and in vitro skin whitening and anti-inflammatory activities","volume":"97","author":"Yun","year":"2013","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"10.1016\/j.intimp.2024.113998_b0165","unstructured":"W.Y. Jang, S.Y. Park, K.Y. Kim, D.Y. Jun, Y.S. Bae, Y.H. Kim, L-AHG-mediated suppression of M1 polarization and pro-inflammatory signaling pathways in LPS-stimulated RAW264.7 macrophages, J. Life Sci. 34 (7) (2024) 443\u2013452. doi: 10.5352\/JLS.2024.34.7.443."},{"key":"10.1016\/j.intimp.2024.113998_b0170","doi-asserted-by":"crossref","first-page":"321","DOI":"10.3390\/md15100321","article-title":"Different levels of skin whitening activity among 3,6-anhydro-L-galactose, agarooligosaccharides, and neoagarooligosaccharides","volume":"15","author":"Kim","year":"2017","journal-title":"Mar. Drugs"},{"issue":"9","key":"10.1016\/j.intimp.2024.113998_b0175","doi-asserted-by":"crossref","first-page":"7643","DOI":"10.1002\/jcb.27112","article-title":"Effect of 3,6-anhydro-l-galactose on \u03b1-melanocyte stimulating hormone-induced melanogenesis in human melanocytes and a skin-equivalent model","volume":"119","author":"Kim","year":"2018","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.intimp.2024.113998_b0180","article-title":"Whole genome sequence of a freshwater agar-degrading bacterium Cellvibrio sp","volume":"23","author":"Kwon","year":"2019","journal-title":"KY-GH-1, Biotechnol. Rep."},{"key":"10.1016\/j.intimp.2024.113998_b0185","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s13568-023-01551-w","article-title":"Extracellular recombinant production of a Cellvibrio thermostable endolytic \u03b2-agarase in Escherichia coli for application in agarose liquefaction","volume":"13","author":"Lee","year":"2023","journal-title":"AMB Express"},{"key":"10.1016\/j.intimp.2024.113998_b0190","doi-asserted-by":"crossref","unstructured":"M.J. Kwon, W.Y. Jang, G.M. Kim, Y.H. Kim, Characterization and application of a recombinant exolytic GH50A \u03b2-agarase from Cellvibrio sp. KY-GH-1 for enzymatic production of neoagarobiose from agarose, ACS Omega 5 (2020) 29453\u201329464. doi: 10.1021\/acsomega.0c04390.","DOI":"10.1021\/acsomega.0c04390"},{"issue":"11","key":"10.1016\/j.intimp.2024.113998_b0195","doi-asserted-by":"crossref","first-page":"4621","DOI":"10.1007\/s00253-021-11341-8","article-title":"Enzymatic characterization of a novel recombinant 1,3-\u03b1-3,6-anhydro-L-galactosidase specific for neoagarobiose hydrolysis into monosaccharides","volume":"105","author":"Jang","year":"2021","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"10.1016\/j.intimp.2024.113998_b0200","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1007\/s10529-008-9634-4","article-title":"Over-production of a glycoside hydrolase family 50 \u03b2-agarase from Agarivorans sp. JA-1 in Bacillus subtilis and the whitening effect of its product","volume":"30","author":"Lee","year":"2008","journal-title":"Biotechnol. Lett"},{"issue":"1","key":"10.1016\/j.intimp.2024.113998_b0205","doi-asserted-by":"crossref","first-page":"17","DOI":"10.4049\/jimmunol.149.1.17","article-title":"Expression of the murine homologue of the cell cycle control protein p34cdc2 in T lymphocytes","volume":"149","author":"Kim","year":"1992","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2024.113998_b0210","doi-asserted-by":"crossref","first-page":"3187","DOI":"10.1073\/pnas.90.8.3187","article-title":"Murine T-lymphocyte proliferation induced by interleukin 2 correlates with a transient increase in p56lck kinase activity and the tyrosine phosphorylation of a 97-kDa protein","volume":"90","author":"Kim","year":"1993","journal-title":"PNAS"},{"issue":"9","key":"10.1016\/j.intimp.2024.113998_b0215","doi-asserted-by":"crossref","first-page":"4328","DOI":"10.4049\/jimmunol.152.9.4328","article-title":"Up-regulation of c-myc induces the gene expression of the murine homologues of p34cdc2 and cyclin-dependent kinase-2 in T lymphocytes","volume":"152","author":"Kim","year":"1994","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2024.113998_b0220","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.cellimm.2013.12.003","article-title":"Requirement of the expression of 3-phosphoglycerate dehydrogenase for traversing S phase in murine T lymphocytes following immobilized anti-CD3 activation","volume":"287","author":"Jun","year":"2014","journal-title":"Cell. Immunol."},{"issue":"7","key":"10.1016\/j.intimp.2024.113998_b0225","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/S0039-9140(97)00017-9","article-title":"A highly water-soluble disulfonated tetrazolium salt as a chromogenic indicator for NADH as well as cell viability","volume":"44","author":"Ishiyama","year":"1997","journal-title":"Talanta"},{"issue":"1","key":"10.1016\/j.intimp.2024.113998_b0230","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1007\/s10495-013-0928-1","article-title":"Prometaphase arrest-dependent phosphorylation of Bcl-2 and Bim reduces the association of Bcl-2 with Bak or Bim, provoking Bak activation and mitochondrial apoptosis in nocodazole-treated Jurkat T cells","volume":"19","author":"Han","year":"2014","journal-title":"Apoptosis"},{"issue":"3","key":"10.1016\/j.intimp.2024.113998_b0235","first-page":"905","article-title":"The effects of methyl (5-(2-thienylcarbonyl)-1H-benzimidazol-2-yl) carbamate, (R 17934; NSC 238159), a new synthetic antitumoral drug interfering with microtubules, on mammalian cells cultured in vitro","volume":"36","author":"De Brabander","year":"1976","journal-title":"Cancer Res."},{"key":"10.1016\/j.intimp.2024.113998_b0240","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.ymeth.2015.02.016","article-title":"Appraising the suitability of succinimidyl and lipophilic fluorescent dyes to track proliferation in non-quiescent cells by dye dilution","volume":"82","author":"Filby","year":"2015","journal-title":"Methods"},{"issue":"4","key":"10.1016\/j.intimp.2024.113998_b0245","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1046\/j.1365-2567.2002.01526.x","article-title":"Tryptophan deprivation sensitizes activated T cells to apoptosis prior to cell division","volume":"107","author":"Lee","year":"2002","journal-title":"Immunology"},{"key":"10.1016\/j.intimp.2024.113998_b0250","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1186\/1471-2164-9-225","article-title":"Comparative analysis of transcriptional profiling of CD3+, CD4+ and CD8+ T cells identifies novel immune response players in T-cell activation","volume":"9","author":"Wang","year":"2008","journal-title":"BMC Genomics"},{"issue":"5","key":"10.1016\/j.intimp.2024.113998_b0255","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1158\/2326-6066.CIR-17-0605","article-title":"Hallmarks of T-cell exit from quiescence","volume":"6","author":"Chapman","year":"2018","journal-title":"Cancer Immunol. Res."},{"issue":"8","key":"10.1016\/j.intimp.2024.113998_b0260","doi-asserted-by":"crossref","first-page":"3111","DOI":"10.1002\/j.1460-2075.1993.tb05980.x","article-title":"The MO15 gene encodes the catalytic subunit of a protein kinase that activates cdc2 and other cyclin-dependent kinases (CDKs) through phosphorylation of Thr161 and its homologues","volume":"12","author":"Fesquet","year":"1993","journal-title":"EMBO J."},{"issue":"14","key":"10.1016\/j.intimp.2024.113998_b0265","doi-asserted-by":"crossref","first-page":"8313","DOI":"10.1074\/jbc.271.14.8313","article-title":"Differential regulation of retinoblastoma protein function by specific Cdk phosphorylation sites","volume":"271","author":"Knudsen","year":"1996","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.intimp.2024.113998_b0270","first-page":"M123","article-title":"Regulation of the retinoblastoma tumor suppressor protein by cyclin\/cdks","volume":"1471","author":"Adams","year":"2001","journal-title":"BBA"},{"issue":"6506","key":"10.1016\/j.intimp.2024.113998_b0275","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1038\/372570a0","article-title":"Interleukin-2-mediated elimination of the p27Kip1 cyclin-dependent kinase inhibitor prevented by rapamycin","volume":"372","author":"Nourse","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.intimp.2024.113998_b0280","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1146\/annurev-immunol-042617-053352","article-title":"Signaling and function of interleukin-2 in T lymphocytes","volume":"36","author":"Ross","year":"2018","journal-title":"Annu. Rev. Immunol."},{"issue":"3","key":"10.1016\/j.intimp.2024.113998_b0285","doi-asserted-by":"crossref","first-page":"826","DOI":"10.4049\/jimmunol.142.3.826","article-title":"Human B cell proliferation in response to IL-4 is associated with enhanced production of B cell-derived growth factors","volume":"142","author":"Tadmori","year":"1989","journal-title":"J. Immunol."},{"issue":"9","key":"10.1016\/j.intimp.2024.113998_b0290","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1136\/thx.54.9.825","article-title":"Cytokines in asthma","volume":"54","author":"Chung","year":"1999","journal-title":"Thorax"},{"issue":"1","key":"10.1016\/j.intimp.2024.113998_b0295","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.cyto.2014.09.011","article-title":"T cell subsets and their signature cytokines in autoimmune and inflammatory diseases","volume":"74","author":"Raphael","year":"2015","journal-title":"Cytokine"},{"issue":"6338","key":"10.1016\/j.intimp.2024.113998_b0300","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1038\/352803a0","article-title":"Nuclear association of a T-cell transcription factor blocked by FK-506 and cyclosporin A","volume":"352","author":"Flanagan","year":"1991","journal-title":"Nature"},{"issue":"6381","key":"10.1016\/j.intimp.2024.113998_b0305","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/358070a0","article-title":"Rapamycin selectively inhibits interleukin-2 activation of p70 S6 kinase","volume":"358","author":"Kuo","year":"1992","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.intimp.2024.113998_b0310","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1006\/bcmd.2001.0420","article-title":"Rapamycin blocks IL-2-driven T cell cycle progression while preserving T cell survival","volume":"27","author":"Gonzalez","year":"2001","journal-title":"Blood Cell Mol. Dis."},{"key":"10.1016\/j.intimp.2024.113998_b0315","doi-asserted-by":"crossref","unstructured":"P.S. Changelian, M.E. Flanagan, D.J. Ball, C.R. Kent, K.S. Magnuson, W.H. Martin, B.J. Rizzuti, P.S. Sawyer, B.D. Perry, W.H. Brissette, S.P. McCurdy, E.M. Kudlacz, M.J. Conklyn, E.A. Elliott, E.R. Koslov, M.B. Fisher, T.J. Strelevitz, K. Yoon, D.A. Whipple, J. Sun, M.J. Munchhof, J.L. Doty, J.M. Casavant, T.A. Blumenkopf, M. Hines, M.F. Brown, B.M. Lillie, C. Subramanyam, C. Shang-Poa, A.J. Milici, G.E. Beckius, J.D. Moyer, C. Su, T.G. Woodworth, A.S. Gaweco, C.R. Beals, B.H. Littman, D.A. Fisher, J.F. Smith, P. Zagouras, H.A. Magna, M.J. Saltarelli, K.S. Johnson, L.F. Nelms, S.G. Des Etages, L.S. Hayes, T.T. Kawabata, D. Finco-Kent, D.L. Baker, M. Larson, M.S. Si, R. Paniagua, J. Higgins, B. Holm, B. Reitz, Y.J. Zhou, R.E. Morris, J.J. O\u2019Shea, D.C. Borie, Prevention of organ allograft rejection by a specific Janus kinase 3 inhibitor, Science 302 (5646) (2003) 875\u2013878. doi: 10.1126\/science.1087061.","DOI":"10.1126\/science.1087061"},{"issue":"8","key":"10.1016\/j.intimp.2024.113998_b0320","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1002\/cyto.990140806","article-title":"Identification and quantitation of apoptotic cells following anti-CD3 activation of murine G0 T cells","volume":"14","author":"Chrest","year":"1993","journal-title":"Cytometry"},{"issue":"1","key":"10.1016\/j.intimp.2024.113998_b0325","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1002\/cyto.990200107","article-title":"Anti-CD3-induced apoptosis in T-cells from young and old mice","volume":"20","author":"Chrest","year":"1995","journal-title":"Cytometry"},{"issue":"1","key":"10.1016\/j.intimp.2024.113998_b0330","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/1074-7613(95)90161-2","article-title":"CD28 costimulation can promote T cell survival by enhancing the expression of Bcl-XL","volume":"3","author":"Boise","year":"1995","journal-title":"Immunity"},{"key":"10.1016\/j.intimp.2024.113998_b0335","doi-asserted-by":"crossref","unstructured":"K. Okkenhaug, L. Wu, K.M Garza, J. La Rose, W. Khoo, B. Odermatt, T.W. Mak, P.S. Ohashi, R. Rottapel, A point mutation in CD28 distinguishes proliferative signals from survival signals, Nat. Immunol. 2 (4) (2001) 325\u2013332. doi: 10.1038\/86327.","DOI":"10.1038\/86327"},{"issue":"10","key":"10.1016\/j.intimp.2024.113998_b0340","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1002\/eji.1830201017","article-title":"Suppression of B cell activation by cyclosporin A, FK506 and rapamycin","volume":"20","author":"Wicker","year":"1990","journal-title":"Eur. J. Immunol."},{"issue":"6","key":"10.1016\/j.intimp.2024.113998_b0345","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.4049\/jimmunol.154.6.2533","article-title":"Endogenous IL-6 and IL-10 contribute to the differentiation of CD40-activated human B lymphocytes","volume":"154","author":"Burdin","year":"1995","journal-title":"J. Immunol."},{"issue":"4","key":"10.1016\/j.intimp.2024.113998_b0350","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1002\/1521-4141(200104)31:4<1150::AID-IMMU1150>3.0.CO;2-V","article-title":"B cells activated via CD40 and IL-4 undergo a division burst but require continued stimulation to maintain division, survival and differentiation","volume":"31","author":"Rush","year":"2001","journal-title":"Eur. J. Immunol."},{"issue":"2 Suppl 2","key":"10.1016\/j.intimp.2024.113998_b0355","doi-asserted-by":"crossref","first-page":"S33","DOI":"10.1016\/j.jaci.2009.09.017","article-title":"Adaptive immunity","volume":"125","author":"Bonilla","year":"2010","journal-title":"J. Allergy Clin. Immunol."},{"issue":"Suppl 2","key":"10.1016\/j.intimp.2024.113998_b0360","first-page":"49","article-title":"An introduction to immunology and immunopathology","volume":"14","author":"Marshall","year":"2018","journal-title":"AllergyAsthma Clin. Immunol."},{"issue":"3","key":"10.1016\/j.intimp.2024.113998_b0365","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a011205","article-title":"The JAK\/STAT pathway","volume":"4","author":"Harrison","year":"2012","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.intimp.2024.113998_b0370","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/s41392-021-00791-1","article-title":"The JAK\/STAT signaling pathway: from bench to clinic","volume":"6","author":"Hu","year":"2021","journal-title":"Sig. Transduct. Target. Ther."},{"key":"10.1016\/j.intimp.2024.113998_b0375","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/nri.2015.18","article-title":"Harnessing the plasticity of CD4+ T cells to treat immune-mediated disease, Nature","volume":"16","author":"DuPage","year":"2016","journal-title":"Rev. Immunol."},{"issue":"3","key":"10.1016\/j.intimp.2024.113998_b0380","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.coi.2012.01.014","article-title":"Helper T cell diversity and plasticity","volume":"24","author":"Nakayamada","year":"2012","journal-title":"Curr. Opin. Immunol."},{"issue":"5","key":"10.1016\/j.intimp.2024.113998_b0385","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.3390\/pharmaceutics14051001","article-title":"A comprehensive overview of globally approved JAK inhibitors","volume":"14","author":"Shawky","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.intimp.2024.113998_b0390","doi-asserted-by":"crossref","first-page":"7140","DOI":"10.1038\/s41598-022-10777-w","article-title":"Adverse events associated with JAK inhibitors in 126,815 reports from the WHO pharmacovigilance database","volume":"12","author":"Hoisnard","year":"2022","journal-title":"Sci. Rep."},{"issue":"11","key":"10.1016\/j.intimp.2024.113998_b0395","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1007\/s40264-023-01333-0","article-title":"Managing cardiovascular and cancer risk associated with JAK inhibitors","volume":"46","author":"Yang","year":"2023","journal-title":"Drug Saf."},{"key":"10.1016\/j.intimp.2024.113998_b0400","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106359","article-title":"Cardiovascular safety, cancer and Jak-inhibitors: Differences to be highlighted","volume":"183","author":"Benucci","year":"2022","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.intimp.2024.113998_b0405","doi-asserted-by":"crossref","unstructured":"S.R. Ytterberg, D.L. Bhatt. T.R. Mikuls, G.G. Koch, R. Fleischmann, J.L. Rivas, R. Germino, S. Menon, Y. Sun, C. Wang, A.B. Shapiro, K.S. Kanik, C.A. Connell, Cardiovascular and cancer risk with tofacitinib in rheumatoid arthritis, N. Engl. J. Med. 386(4) (2022) 316-326. doi: 10.1056\/NEJMoa2109927.","DOI":"10.1056\/NEJMoa2109927"},{"key":"10.1016\/j.intimp.2024.113998_b0410","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/s41581-023-00720-1","article-title":"Pathogenesis of autoimmune disease","volume":"19","author":"Pisetsky","year":"2023","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.intimp.2024.113998_b0415","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/s41392-023-01377-9","article-title":"Activation of immune signals during organ transplantation","volume":"8","author":"Li","year":"2023","journal-title":"Sig. Transduct. Target. Ther."},{"issue":"7","key":"10.1016\/j.intimp.2024.113998_b0420","doi-asserted-by":"crossref","first-page":"3406","DOI":"10.1172\/JCI138122","article-title":"The contribution of B cells to transplantation tolerance","volume":"130","author":"Graca","year":"2020","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.intimp.2024.113998_b0425","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1190379","article-title":"Cytokine release syndrome and cancer immunotherapies \u2013 historical challenges and promising futures","volume":"14","author":"Shah","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2024.113998_b0430","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.900594","article-title":"Xenotransplantation: A new era","volume":"13","author":"Carrier","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2024.113998_b0435","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2019.104967","article-title":"Successful oral delivery of poorly water-soluble drugs both depends on the intraluminal behavior of drugs and of appropriate advanced drug delivery systems","volume":"137","author":"Boyd","year":"2019","journal-title":"Eur. J. Pharm. Sci."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576924025207?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576924025207?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T04:27:03Z","timestamp":1740112023000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576924025207"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":87,"alternative-id":["S1567576924025207"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2024.113998","relation":{},"ISSN":["1567-5769"],"issn-type":[{"type":"print","value":"1567-5769"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"3,6-Anhydro-L-galactose suppresses mouse lymphocyte proliferation by attenuating JAK-STAT growth factor signal transduction and G1-S cell cycle progression","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2024.113998","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"113998"}}